The data is improving, the regulatory environment is more favorable, and the safety profile remains strong
In terms of clinical outcomes, T2DM patients with MASLD have a 15% incidence of cirrhosis and a 7% incidence of hepatocellular carcinoma (HCC) within 10 years, alongside a 2.3-fold increased risk of cardiovascular events, underscoring the synergistic harm of multi-system metabolic dysregulation 9,10
TUDCA The Bile-Flow Corrector Supports: biliary drainage, mitochondrial safety, hepatocyte survival Specializes In: PFAS, lipophilic pesticides, flame retardants Why it matters: without bile flow, toxins cycle endlessly TUDCA thins bile, prevents gallbladder stagnation, and allows bile-exported toxins to leave instead of being re-absorbed across the gut wall
Furthermore, it has been suggested that Atf3 and Ddit3 are activated by ER stress and induce apoptosis in UV-exposed LECs 64
Gut microbiota: a new target for traditional Chinese medicine in the treatment of depression